Parametric Portfolio Associates’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $622K | Buy |
71,392
+51,480
| +259% | +$449K | ﹤0.01% | 2994 |
|
|
2021
Q4 | $189K | Sell |
19,912
-51,133
| -72% | -$485K | ﹤0.01% | 3437 |
|
|
2021
Q3 | $1.2M | Buy |
71,045
+5,866
| +9% | +$98.7K | ﹤0.01% | 2719 |
|
|
2021
Q2 | $995K | Buy |
65,179
+50,489
| +344% | +$771K | ﹤0.01% | 2773 |
|
|
2021
Q1 | $286K | Sell |
14,690
-14,129
| -49% | -$275K | ﹤0.01% | 3736 |
|
|
2020
Q4 | $519K | Buy |
28,819
+396
| +1% | +$7.13K | ﹤0.01% | 3365 |
|
|
2020
Q3 | $548K | Buy |
28,423
+3,095
| +12% | +$59.7K | ﹤0.01% | 3226 |
|
|
2020
Q2 | $662K | Buy |
25,328
+579
| +2% | +$15.1K | ﹤0.01% | 3127 |
|
|
2020
Q1 | $442K | Buy |
24,749
+3,792
| +18% | +$67.7K | ﹤0.01% | 3231 |
|
|
2019
Q4 | $699K | Buy |
20,957
+1,237
| +6% | +$41.3K | ﹤0.01% | 3236 |
|
|
2019
Q3 | $470K | Buy |
19,720
+13,627
| +224% | +$325K | ﹤0.01% | 3373 |
|
|
2019
Q2 | $219K | Buy |
+6,093
| New | +$219K | ﹤0.01% | 3707 |
|